Documents & Downloads

HPV16-E711-20 epitope

HPV Epitope

HPV16-E711-20 epitope is an HLA-A*0201-restricted cytotoxic T lymphocyte (CTL) epitope derived from the HPV16 E7 protein, exhibiting high-affinity binding to HLA-A2 in vitro. This epitope plays a critical role in eliciting immune responses against HPV16, making it a promising candidate for the development of peptide-based antitumor vaccines. Its application in cancer immunotherapy research enhances the understanding of HPV-related malignancies and immune evasion mechanisms.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
CAS Number	160040-04-0
Applications	HPV Epitope
Formula	C₅₃H₈₃N₁₁O₁₉S
Molecular Weight	1210.35
SMILES	C([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@H](CC1=CC=C(O)C=C1)N)=O)CCSC)=O)CC(C)C)=O)CC(O)=O)=O)CC(C)C)=O)CCC(N)=O)(=O)N2[C@H](C(N[C@H](C(N[C@H](C(N[C@@H]([C@@H](C)O)C(O)=O)=O)[C@@H](C)O)=O)CCC(O)=O)=O)CCC2

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.